Latest News in the pharma Industry

Market News

Bosch expands pharmaceutical portfolio

Bosch expands pharmaceutical portfolio

26 Oct 2016

New solutions for the packaging process.

Read more 
Teva and IBM expand global partnership to enable drug development and chronic disease management with Watson

Teva and IBM expand global partnership to enable drug development and chronic disease management with Watson

26 Oct 2016

Programs include a systematic approach to drug repurposing and data-driven, proactive chronic disease management - both fueled by the IBM Watson Health Cloud.

Read more 
Clobazam oral suspension approved in seven European countries

Clobazam oral suspension approved in seven European countries

25 Oct 2016

Provides pan-European availability of widely used and much needed oral liquid version clobazam tablets.

Read more 
Amgen to invest in Israel-based eHealth Ventures

Amgen to invest in Israel-based eHealth Ventures

25 Oct 2016

Investment reflects Amgen's commitment to serving patients by driving innovation and sustainable healthcare through technology discovery.

Read more 
FDA approves Merck’s Keytruda in metastatic NSCLC

FDA approves Merck’s Keytruda in metastatic NSCLC

25 Oct 2016

Approval is for first-line treatment of patients whose tumours have high PD-L1 expression with no EGFR or ALK genomic tumour aberrations.

Read more 
Pharma prospers with CPhI Worldwide attracting a record 42,000 attendees, as new industry trends emerge

Pharma prospers with CPhI Worldwide attracting a record 42,000 attendees, as new industry trends emerge

24 Oct 2016

Executives emphasised the importance of being first to market, two distinct outsourcing strategies, with biopharm and HPAPIs segments reporting strong growth.

Read more 
Depression drugs sales in the US will reach $4.6 billion by 2025

Depression drugs sales in the US will reach $4.6 billion by 2025

24 Oct 2016

The US will not only remain the largest major market for MDD drugs, but will extend its lead over other countries, says GlobalData.

Read more 
Pfizer announces US availability of biosimilar Inflectra

Pfizer announces US availability of biosimilar Inflectra

21 Oct 2016

Inflectra will be the first biosimilar monoclonal antibody (mAb) to be available in the US.

Read more 
3D cell culture experts assemble for inaugural New Frontiers in 3D Conference

3D cell culture experts assemble for inaugural New Frontiers in 3D Conference

21 Oct 2016

Keynote speaker says traditional monolayer cell culture models used to study tumour chemoresistance have proven to be woefully inadequate.

Read more 
Hikma Ventures invests in Propeller Health for the enhancement of leading respiratory technology platform

Hikma Ventures invests in Propeller Health for the enhancement of leading respiratory technology platform

20 Oct 2016

Propeller Health has developed a digital platform that integrates information from multiple sources and uses machine intelligence to recommend an optimal path therapy for individuals who suffer from COPD, asthma and other respiratory diseases.

Read more 
SOTIO and NBE Therapeutics sign collaboration and license agreement for next-generation ADCs

SOTIO and NBE Therapeutics sign collaboration and license agreement for next-generation ADCs

20 Oct 2016

Collaboration will focus on the discovery, non-clinical development and manufacturing of novel ADC products against undisclosed targets.

Read more 
Industry expert Kunal Jaiswal to head strategic development for Catalent's clinical supply services business

Industry expert Kunal Jaiswal to head strategic development for Catalent's clinical supply services business

20 Oct 2016

Will lead the company’s ongoing efforts to anticipate and act upon industry trends and technologies that may affect study sponsors, clinical sites, and patients, and to inform the development and delivery of current and future clinical supply services.

Read more